Applied Therapeutics, Inc. (APLT)
NASDAQ: APLT · Real-Time Price · USD
0.2166
-0.0133 (-5.79%)
At close: Dec 5, 2025, 4:00 PM EST
0.2224
+0.0058 (2.68%)
After-hours: Dec 5, 2025, 7:59 PM EST

Applied Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Net Income
-18.14-105.62-119.76-82.51-105.58-93.96
Upgrade
Depreciation & Amortization
0.410.430.350.440.420.38
Upgrade
Stock-Based Compensation
11.8413.477.369.611.188.03
Upgrade
Other Operating Activities
-78.624.9158.323.213.88-0.36
Upgrade
Change in Accounts Payable
1.892.69-2.79-4.938.82-8.04
Upgrade
Change in Other Net Operating Assets
-4.22-0.171.35-3.92-9.4415.75
Upgrade
Operating Cash Flow
-86.85-84.31-55.17-78.09-90.73-78.21
Upgrade
Investment in Securities
--13.8713.1712.43-19.47
Upgrade
Investing Cash Flow
--13.8713.1712.43-19.47
Upgrade
Short-Term Debt Repaid
--0.31-1.86-3.27-4.72-2.15
Upgrade
Total Debt Repaid
--0.31-1.86-3.27-4.72-2.15
Upgrade
Net Debt Issued (Repaid)
--0.31-1.86-3.27-4.72-2.15
Upgrade
Issuance of Common Stock
0.02114.1274.8527.8675.17136.66
Upgrade
Other Financing Activities
-0.1-1.553.114.271.78
Upgrade
Financing Cash Flow
-0.08113.8174.5427.6974.72136.29
Upgrade
Net Cash Flow
-86.9229.533.24-37.23-3.5838.62
Upgrade
Levered Free Cash Flow
-128.16-92.517.74-33.86-50.75-43.09
Upgrade
Unlevered Free Cash Flow
-128.16-92.517.74-33.86-50.75-43.09
Upgrade
Change in Working Capital
-2.342.52-1.44-8.84-0.617.71
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q